Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Cash from Investing Activities (2022 - 2023)

Bluejay Diagnostics' Cash from Investing Activities history spans 2 years, with the latest figure at -$87894.0 for Q4 2023.

  • For Q4 2023, Cash from Investing Activities rose 63.1% year-over-year to -$87894.0; the TTM value through Dec 2023 reached -$704166.0, up 41.28%, while the annual FY2024 figure was -$306783.0, 56.43% up from the prior year.
  • Cash from Investing Activities for Q4 2023 was -$87894.0 at Bluejay Diagnostics, down from -$74498.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$46346.0 in Q1 2022 and bottomed at -$791464.0 in Q3 2022.